Press Room

2024 DPI Symposium

Start
Thursday, November 07, 2024 - 09:00
End
Thursday, November 07, 2024 - 18:00
Location: Toyama, Japan

The DPI Symposium is a must go Conference in Japan for inhalation trends.

Hovione team will be available to present our one-site solution for inhalation and nasal that includes a full range of devices to support our customers’ needs.

With 60+ years of in-country presence and active business, we are ready to present you how a fully integrated CDMO can provide optimal solutions for your drug product development with the right scale and flexibility. 

60年以上の日本でのビジネスを通して、どのように総合的なCDMOとして適した規模と柔軟性を以て医薬品開発に最適な解決策をご提供できるかご紹介致します。

 

Schedule a meeting today. Let's discuss your project together.

あなたのプロジェクトについて一緒にお話しませんか

schedule a meeting

 

 

 

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025